Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31221773.
- Also identified by DOI 10.1126/science.aav9518 and PMC identifier 6658218.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cerebral blood flow is reduced early in the onset of Alzheimer's disease (AD). Because most of the vascular resistance within the brain is in capillaries, this could reflect dysfunction of contractile pericytes on capillary walls. We used live and rapidly fixed biopsied human tissue to establish disease relevance, and rodent experiments to define mechanism. We found that in humans with cognitive decline, amyloid β (Aβ) constricts brain capillaries at pericyte locations. This was caused by Aβ generating reactive oxygen species, which evoked the release of endothelin-1 (ET) that activated pericyte ET<sub>A</sub> receptors. Capillary, but not arteriole, constriction also occurred in vivo in a mouse model of AD. Thus, inhibiting the capillary constriction caused by Aβ could potentially reduce energy lack and neurodegeneration in AD.
Medical subject headings
- Alzheimer Disease
- Amyloid beta-Peptides
- Capillaries
- Cerebral Cortex
- Cerebrovascular Circulation
- Constriction, Pathologic
- Pericytes